Physician

Yu Tang James Su, MD

According to 2025 Medicare claims, Yu Su, MD (NPI: 1932135043) practices ophthalmology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is YUTANG SU MD PLLC (NPI: 1447561915; TIN: 264472604) and primary practice location at 78572-3490.

Su's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 299 traditional Medicare patients, billed 5,353 HCPCS/CPT codes, and received $346,254 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 612 prescription claims across 178 beneficiaries totaling $30,709 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 6 records totaling $274. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $551,191 to $346,254. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$310K$620K2015 Medicare payment: $551,191 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $605,255 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $619,912 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $578,766 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $538,699 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $500,943 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $426,768 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $412,638 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $385,943 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $346,254 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0204,076$551,191
20169844,713$605,255
20179664,888$619,912
20188294,464$578,766
20195683,692$538,699
20204943,236$500,943
20214452,698$426,768
20223942,444$412,638
20233143,730$385,943
20242995,353$346,254

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$31K$62K2015 Drug cost: $41,302 (USD; Tot_Drug_Cst)2016 Drug cost: $57,553 (USD; Tot_Drug_Cst)2017 Drug cost: $61,937 (USD; Tot_Drug_Cst)2018 Drug cost: $42,637 (USD; Tot_Drug_Cst)2019 Drug cost: $46,389 (USD; Tot_Drug_Cst)2020 Drug cost: $33,345 (USD; Tot_Drug_Cst)2021 Drug cost: $39,265 (USD; Tot_Drug_Cst)2022 Drug cost: $40,314 (USD; Tot_Drug_Cst)2023 Drug cost: $42,428 (USD; Tot_Drug_Cst)2024 Drug cost: $30,709 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015219650$41,302
2016226695$57,553
2017229630$61,937
2018192509$42,637
2019166509$46,389
2020153458$33,345
2021163546$39,265
2022172564$40,314
2023173626$42,428
2024178612$30,709

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9090$101
67028Injection of drug into eye89294$68
92014Established patient complete exam of visual system117119$65
92012Established patient problem focused exam of visual system101147$53
92134Imaging of retina217371$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2176,700$6,573
IlevroNepafenac15347$5,869
CombiganBrimonidine Tartrate/Timolol20689$4,936
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol17725$2,782
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat1449,230$2,032

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$274Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Yu Tang James Su, MD?

Tedicare shows public-source Medicare data for Yu Tang James Su, MD (NPI 1932135043), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yu Tang James Su, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yu Tang James Su, MD?

Yu Tang James Su, MD is linked to YUTANG SU MD PLLC (billing NPI 1447561915) in the available physician profile data.

Does Yu Tang James Su, MD have Open Payments data?

Yu Tang James Su, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.